The Venture Codex Logo

The Venture Codex

Adjuvant Capital

500 5th Avenue, Suite 4000, New York, NY, 10110, United States

Overview

Life sciences investment firm targeting global health solutions.

Founded

2012

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

Denmark
Switzerland
United Kingdom
United States

Sector focus

Financial Services
Health Care
Venture Capital

Investment portfolio

29rounds
NAMEDATESIZE
VitriVax
Oct 2025Led
$17 MSeries B
Curevo
Mar 2025Participated
$110 MSeries B
Memo Therapeutics
May 2024Participated
$22 MSeries C
Orange Dental
Jan 2024Participated
$130 MSeries B
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
Minervax
Oct 2023Participated
$57 MOther Equity
LimmaTech Biologics
Oct 2023Led
$36 MSeries A
Antiva Biosciences
Apr 2023Participated
$53 MSeries E
Codagenix
Feb 2023Participated
$25 MSeries B
InDevR
Jan 2023Led
$9 MSeries B
Minervax
Dec 2022Participated
$77 MDebt
Pulmocide
Dec 2022Participated
$52 MSeries C
VitriVax
Oct 2025Led
$17 MSeries B
Curevo
Mar 2025Participated
$110 MSeries B
Memo Therapeutics
May 2024Participated
$22 MSeries C
Orange Dental
Jan 2024Participated
$130 MSeries B
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
Minervax
Oct 2023Participated
$57 MOther Equity
LimmaTech Biologics
Oct 2023Led
$36 MSeries A
Antiva Biosciences
Apr 2023Participated
$53 MSeries E
Codagenix
Feb 2023Participated
$25 MSeries B
InDevR
Jan 2023Led
$9 MSeries B
Minervax
Dec 2022Participated
$77 MDebt
Pulmocide
Dec 2022Participated
$52 MSeries C
29
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Adjuvant Capital: 29 funding rounds are recorded in the selected participation categories.All available history.
Adjuvant Capital: 29 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A34
Series B47
Series C+26
Other Equity02
Debt01

Monthly Deal Activity

Adjuvant Capital: 29 deals are recorded across 88 months.All available history.
Adjuvant Capital: 29 deals are recorded across 88 months. All available history
MonthDeals
Jul '191
Aug '190
Sep '192
Oct '190
Nov '191
Dec '190
Jan '201
Feb '200
Mar '200
Apr '201
May '201
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '201
Jan '210
Feb '212
Mar '211
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '211
Dec '210
Jan '220
Feb '222
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '222
Jan '231
Feb '231
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '232
Nov '231
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Adjuvant Capital: Health & Life Sciences is the largest displayed sector by deal count (28 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Adjuvant Capital: Health & Life Sciences is the largest displayed sector by deal count (28 deals). All available history
SectorDeals
Health & Life Sciences28
Networks, Cloud & Communication3
Manufacturing3
Professional Services1
Consumer & Lifestyle1

Deal Size Distribution

Adjuvant Capital: 29 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Adjuvant Capital: 29 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M3
$10M-$25M6
$25M-$50M8
$50M-$100M9
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Adjuvant Capital: United States has the largest recorded deal count among the displayed regions (17 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Adjuvant Capital: United States has the largest recorded deal count among the displayed regions (17 deals). All available history
RegionDeals
United States17
Europe10
Hong Kong1
China1
Adjuvant Capital: 20 co-investors are shown, with F-Prime Capital sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Adjuvant Capital: 20 co-investors are shown, with F-Prime Capital sharing 4 recorded deals. All available history
Co-investorShared deals
F-Prime Capital4
OrbiMed4
Pureos Bioventures4
RA Capital Management4
Sanofi Ventures4
Wellington Partners4
Fresenius Medical Care Ventures3
GF Group3
Green Cross Holdings3
Industrifonden3
Janus Henderson Investors3
Johnson & Johnson Innovation3
Novo Holdings3
Sunstone Life Science Ventures3
Swisscanto Invest3
Verve Ventures3
Vesalius Biocapital3
3W Capital2
AIHC Capital2
Alexandria Venture Investments2

Investment Strategy

Adjuvant Capital: Led accounts for 31% and participating for 69% of round participation.All available history.
Adjuvant Capital: Led accounts for 31% and participating for 69% of round participation. All available history
CategoryDeals (count)Share (%)
Led931%
Participating2069%
Adjuvant Capital: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Adjuvant Capital: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead667%
Co-led333%

Team

Charlie Petty

Principal and Co-Founder

Glenn Rockman

Founder and Managing Partner

Jenny Yip

Managing Partner

Kabeer Aziz

Principal

Michael Chang

Principal

Philippe Dro

Partner